Tilaknagar Industries Ltd
NSE:TI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tilaknagar Industries Ltd
NSE:TI
|
IN |
|
Innovent Biologics Inc
HKEX:1801
|
CN |
|
K
|
Kitakei Co Ltd
TSE:9872
|
JP |
Balance Sheet
Balance Sheet Decomposition
Tilaknagar Industries Ltd
Tilaknagar Industries Ltd
Balance Sheet
Tilaknagar Industries Ltd
| Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
11
|
19
|
185
|
80
|
134
|
204
|
85
|
238
|
105
|
60
|
683
|
502
|
373
|
449
|
427
|
348
|
103
|
157
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
204
|
85
|
238
|
95
|
49
|
668
|
502
|
368
|
7
|
7
|
53
|
87
|
157
|
|
| Cash Equivalents |
11
|
19
|
185
|
80
|
134
|
0
|
0
|
0
|
10
|
11
|
15
|
0
|
5
|
442
|
420
|
296
|
17
|
0
|
|
| Short-Term Investments |
10
|
29
|
81
|
86
|
63
|
28
|
100
|
103
|
1 385
|
1 084
|
508
|
60
|
22
|
31
|
279
|
314
|
308
|
956
|
|
| Total Receivables |
1 026
|
1 277
|
2 958
|
3 885
|
4 525
|
5 887
|
6 923
|
7 156
|
1 334
|
1 497
|
1 733
|
3 214
|
1 957
|
1 346
|
1 891
|
2 951
|
3 709
|
3 712
|
|
| Accounts Receivables |
550
|
654
|
820
|
966
|
1 291
|
2 020
|
2 224
|
1 486
|
1 333
|
1 497
|
1 731
|
2 410
|
2 434
|
1 811
|
2 368
|
3 443
|
4 269
|
4 227
|
|
| Other Receivables |
476
|
623
|
2 138
|
2 919
|
3 234
|
3 867
|
4 699
|
5 670
|
1
|
0
|
2
|
804
|
477
|
465
|
476
|
492
|
559
|
515
|
|
| Inventory |
214
|
592
|
843
|
813
|
1 303
|
1 332
|
1 326
|
1 262
|
1 208
|
882
|
800
|
978
|
1 282
|
1 422
|
1 245
|
1 728
|
1 644
|
2 393
|
|
| Other Current Assets |
0
|
0
|
13
|
21
|
42
|
129
|
91
|
78
|
3 996
|
3 086
|
755
|
68
|
99
|
143
|
358
|
173
|
104
|
233
|
|
| Total Current Assets |
1 262
|
1 917
|
4 080
|
4 886
|
6 068
|
7 580
|
8 524
|
8 838
|
8 029
|
6 609
|
4 480
|
4 822
|
3 733
|
3 391
|
4 200
|
5 515
|
5 852
|
7 452
|
|
| PP&E Net |
1 212
|
1 749
|
3 699
|
4 141
|
5 063
|
5 557
|
6 440
|
6 878
|
6 669
|
6 334
|
6 729
|
6 422
|
6 017
|
5 683
|
5 392
|
4 198
|
3 962
|
3 726
|
|
| PP&E Gross |
1 212
|
1 749
|
3 699
|
0
|
0
|
5 557
|
6 440
|
6 878
|
0
|
0
|
0
|
6 422
|
6 017
|
5 683
|
5 392
|
4 198
|
3 962
|
3 726
|
|
| Accumulated Depreciation |
107
|
174
|
272
|
0
|
0
|
846
|
1 089
|
1 358
|
0
|
0
|
0
|
2 620
|
2 947
|
3 270
|
3 593
|
3 911
|
4 227
|
4 528
|
|
| Intangible Assets |
10
|
9
|
7
|
121
|
86
|
58
|
252
|
183
|
136
|
91
|
46
|
4
|
4
|
4
|
3
|
3
|
5
|
4
|
|
| Goodwill |
4
|
39
|
39
|
86
|
254
|
254
|
254
|
254
|
233
|
233
|
233
|
233
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
388
|
10
|
669
|
1 118
|
935
|
83
|
90
|
18
|
1 320
|
1 046
|
1 036
|
537
|
393
|
407
|
732
|
|
| Long-Term Investments |
24
|
0
|
3
|
0
|
0
|
17
|
17
|
17
|
2
|
3
|
575
|
7
|
1
|
1
|
1
|
6
|
108
|
214
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
114
|
57
|
41
|
58
|
195
|
145
|
761
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
4
|
39
|
39
|
86
|
254
|
254
|
254
|
254
|
233
|
233
|
233
|
233
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2 512
N/A
|
3 714
+48%
|
7 828
+111%
|
9 622
+23%
|
11 595
+21%
|
14 193
+22%
|
16 646
+17%
|
17 164
+3%
|
15 346
-11%
|
13 504
-12%
|
12 841
-5%
|
12 811
0%
|
10 801
-16%
|
10 115
-6%
|
10 133
+0%
|
10 115
0%
|
10 334
+2%
|
12 128
+17%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
5
|
0
|
0
|
328
|
492
|
986
|
733
|
1 538
|
1 737
|
1 660
|
1 628
|
1 947
|
1 553
|
1 480
|
1 713
|
1 292
|
1 207
|
1 478
|
|
| Accrued Liabilities |
0
|
0
|
0
|
18
|
19
|
37
|
30
|
35
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
40
|
2 984
|
3 671
|
4 200
|
5 176
|
5 789
|
6 543
|
7 574
|
7 703
|
8 153
|
500
|
558
|
2 040
|
2 291
|
284
|
180
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
382
|
401
|
311
|
886
|
349
|
2 737
|
3 148
|
2 611
|
2 955
|
387
|
661
|
1
|
3
|
281
|
145
|
|
| Other Current Liabilities |
707
|
975
|
1 147
|
288
|
506
|
444
|
659
|
605
|
623
|
388
|
1 086
|
1 173
|
1 113
|
1 217
|
638
|
756
|
784
|
850
|
|
| Total Current Liabilities |
712
|
975
|
1 187
|
4 001
|
5 088
|
5 978
|
7 484
|
8 316
|
11 639
|
12 769
|
13 028
|
14 227
|
3 553
|
3 917
|
4 393
|
4 341
|
2 556
|
2 652
|
|
| Long-Term Debt |
577
|
1 251
|
4 494
|
991
|
1 146
|
2 112
|
2 256
|
2 112
|
0
|
0
|
1
|
1
|
4 899
|
4 591
|
3 811
|
261
|
649
|
117
|
|
| Deferred Income Tax |
34
|
62
|
120
|
199
|
281
|
330
|
384
|
462
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
371
|
330
|
460
|
693
|
851
|
706
|
530
|
1 113
|
1 455
|
2 522
|
2 165
|
594
|
684
|
590
|
536
|
|
| Total Liabilities |
1 322
N/A
|
2 288
+73%
|
5 801
+154%
|
5 561
-4%
|
6 844
+23%
|
8 880
+30%
|
10 817
+22%
|
11 741
+9%
|
12 352
+5%
|
13 299
+8%
|
14 141
+6%
|
15 683
+11%
|
10 974
-30%
|
10 672
-3%
|
8 798
-18%
|
5 286
-40%
|
3 796
-28%
|
3 306
-13%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
57
|
139
|
323
|
1 153
|
1 200
|
1 219
|
1 238
|
1 248
|
1 248
|
1 248
|
1 248
|
1 251
|
1 251
|
1 254
|
1 586
|
1 853
|
1 927
|
1 936
|
|
| Retained Earnings |
218
|
401
|
717
|
580
|
940
|
1 432
|
1 898
|
1 452
|
330
|
3 084
|
2 548
|
6 163
|
3 467
|
3 845
|
3 390
|
1 912
|
582
|
1 604
|
|
| Additional Paid In Capital |
92
|
92
|
224
|
1 595
|
1 908
|
1 989
|
2 051
|
2 080
|
1 988
|
1 988
|
0
|
1 992
|
1 992
|
1 995
|
3 092
|
4 827
|
5 112
|
5 183
|
|
| Unrealized Security Profit/Loss |
823
|
793
|
763
|
733
|
703
|
672
|
642
|
642
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
89
|
53
|
0
|
48
|
50
|
39
|
46
|
61
|
81
|
99
|
|
| Total Equity |
1 190
N/A
|
1 425
+20%
|
2 027
+42%
|
4 061
+100%
|
4 751
+17%
|
5 313
+12%
|
5 829
+10%
|
5 422
-7%
|
2 994
-45%
|
204
-93%
|
1 300
N/A
|
2 872
-121%
|
174
+94%
|
557
-220%
|
1 335
N/A
|
4 829
+262%
|
6 539
+35%
|
8 822
+35%
|
|
| Total Liabilities & Equity |
2 512
N/A
|
3 714
+48%
|
7 828
+111%
|
9 622
+23%
|
11 595
+21%
|
14 193
+22%
|
16 646
+17%
|
17 164
+3%
|
15 346
-11%
|
13 504
-12%
|
12 841
-5%
|
12 811
0%
|
10 801
-16%
|
10 115
-6%
|
10 133
+0%
|
10 115
0%
|
10 334
+2%
|
12 128
+17%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
52
|
52
|
97
|
115
|
120
|
122
|
124
|
125
|
125
|
125
|
125
|
125
|
125
|
125
|
159
|
185
|
193
|
194
|
|